Annie Yoshiyama
SVP, Finance · Allogene Therapeutics, Inc.
- 2026
- Apr 23, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Annie Yoshiyama files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David D. Chang - $289K in ALLO purchases and sales in the last 12 months
- Zachary Roberts - $104K in ALLO purchases and sales in the last 12 months
- Earl Martin Douglas - $103K in ALLO purchases and sales in the last 12 months
- Geoffrey M. Parker - $88K in ALLO purchases and sales in the last 12 months
- Benjamin Machinas Beneski - $52K in ALLO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Annie Yoshiyama?
Annie Yoshiyama is a corporate insider, tracked as SVP, Finance of Allogene Therapeutics, Inc. (ALLO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Annie Yoshiyama last file a Form 4?
The most recent primary Form 4 on record is dated 23 April 2026, one of 2 filings going back to 2026.
Has Annie Yoshiyama been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($29K) across all tracked filings.
